A Agência Reguladora Nacional do Brasil, Anvisa, realizou uma série de ações regulatórias e informativas para lidar com a emergência internacional de saúde pública relacionada ao SARS-CoV-2 (um novo tipo de coronavírus), causador do COVID-19. Todas essas ações estão reunidas em: http://portal.anvisa.gov.br/coronavirus.
FDA emite autorização de uso em emergência (EUA) que permite ouso de sulfato de hidroxicloroquina e fosfato de cloroquina doados para distribuição e uso em paciientes com COVID-19: clique aqui para ler esta notícia
FDA realiza revisão rápida de testes de diagnóstico para combater o COVID-19: review of diagnostic tests
TOPIC: Chloroquine Phosphate Intended for Fish: FDA Letter to Stakeholders – Do Not Use as Treatment for COVID-19 in Humans
AUDIENCE: Consumer, Health Professional
ISSUE: The FDA’s Center for Veterinary Medicine has recently become aware that some consumers may mistake chloroquine phosphate used to treat disease in aquarium fish for FDA-approved drugs (used to treat malaria and certain other conditions in humans) that are being studied as a COVID-19 treatment for humans. Unfortunately, we have learned that one person in the United States has died after he and his wife reportedly took chloroquine used to treat their fish in an attempt to prevent COVID-19; his wife also became very ill.
Our primary concern during the COVID-19 pandemic is the imminent threat to the health of consumers who may take animal drugs thinking they are interchangeable with approved human drugs.
Lista de medicamentos esenciales para el manejo de pacientes que ingresan a unidades de cuidados intensivos con sospecha o diagnóstico confirmado de COVID-19 [Es]
